Share Name Share Symbol Market Type Share ISIN Share Description
Omega Dia LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 16.50p 16.00p 17.00p 16.50p 16.50p 16.50p 0 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 14.2 0.7 1.1 15.0 20.95

Omega Diagnostics Share Discussion Threads

Showing 2276 to 2300 of 2300 messages
Chat Pages: 92  91  90  89  88  87  86  85  84  83  82  81  Older
DateSubjectAuthorDiscuss
16/1/2018
08:50
On that theme, Omega are advertising for an Export Sales Coordinator: Https://twitter.com/OmegaDiagnostic
hyperboreus
16/1/2018
08:27
IDS, Starting to put deals together. Now for the IDS/ODX Tie-up>>> Immunodiagnostic Systems Holdings plc ("IDS"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, today announces that it has reached agreement with Technogenetics srl ("TGS") to enable IDS to sell TGS's range of assay kits under the IDS brand, on a global basis. TGS produces a broad range of CE approved CLIA automated assay kits for use in the fields of autoimmune and infectious disease diagnostics, which have been developed for the IDS iSYS analyser.
barrywhit
12/1/2018
19:12
A late trade showing from yesterday 127.5k and the late trade from today 85k, both buys...
barrywhit
12/1/2018
14:37
That explains it - it wasn't on RNS. Will look at the header in future :o)) Good to see him continue to have so much faith in ODX.
rivaldo
12/1/2018
14:00
Rivaldo, ODX updated their website last September, I got longshanks to update the header above.....it's there for all to see... edit: he bought the remainder in the last placing over 2 million at 18p.....
barrywhit
12/1/2018
13:53
Cheers barry - but I can't see any holdings RNS from ODX re Sneller in September? The last one I can see per Investegate is from 21st April, when he had the 14.19m. Cheers.
rivaldo
12/1/2018
13:20
Good to see he is still buying and not the seller, which was probably Harwood Capital....IMO
barrywhit
12/1/2018
13:16
Anyhow what is most important is that he thinks ODX is still worthwhile investing in, on the other hand someone else doesn't! 🤓
hyperboreus
12/1/2018
12:49
Hi Rivaldo, No he had - Richard Sneller 16,409,157 12.92% as of September 2017 above...
barrywhit
12/1/2018
12:44
Indeed - he's now got 17.79m shares - his last holding was only 14.19m, so he's added around 3.6m shares..... Https://www.investegate.co.uk/omega-diagnostics-gp--odx-/rns/holding-s--in-company/201801121214417661B/
rivaldo
12/1/2018
12:40
Richard Sneller still adding to his holding......he has added another 1.3 million
barrywhit
11/1/2018
12:49
Looks like the 16p overhang has gone, now paying almost 17p....
barrywhit
02/1/2018
10:47
Happy New Year Lads.......... I see we still have sellers.........
barrywhit
22/12/2017
09:42
Took a few yesterday happy buying the dip and as rivaldo say's there may be another positive announcement early next year time will tell :-)
cheshire man
21/12/2017
07:51
I think that is the first time they have issued a specific RNS when they have received CE Mark for Allergens....normally they just put it in the updates, well done Colin King...
barrywhit
21/12/2017
07:43
Quite apart from the good news re the allergens, it's notable that ODX go so far out on a limb to emphasise: "we remain positive that we will conclude commercialisation discussions with Immunodiagnostic Systems in the near future." I'd guess there'll be an announcement in the New Year (Jan/Feb) if all goes smoothly.
rivaldo
21/12/2017
07:29
A good and positive RNS. All power to Colin King.
verger
18/12/2017
09:26
Fair plays to you Dibs: I wish you good fortune.No doubt "the cobra" will be back here in due course.
longshanks
17/12/2017
23:03
Just for clarification I wasn’t ‘scared’ into selling out (as a PI). It was opportunistic. I spotted what I regard as a better short/medium term opportunity elsewhere. I remain a long term believer in this stock and I am sure I’ll be back but sometimes you have to be ruthless in the AIM market and in the short term I don’t think this is going anywhere. It’ll probably recover to around 16-18p but I doubt anymore until they can show they’ve recovered from the short term headwinds. Meanwhile, hopefully there’s money to be made elsewhere. ATB to all investors here. Hopefully your patience will be rewarded.
dibs61
16/12/2017
07:26
Turnover of stock has been quite low considering, but the MM's played a blinder dropping the bid to 16p on opening that scared a few PI's into selling out. Hopefully we will see a slow climb backup to 18 to 20p....
barrywhit
16/12/2017
00:27
I can understand some people selling. The turnover in stock hasn't been huge though.
p1nkfish
15/12/2017
16:23
Dibs was the seller today just posted on the LSE thread, wished him good luck...
barrywhit
15/12/2017
16:01
The confidence in the article of the CEO in CD4 in being "not a case of if but when" is welcome: "Mr Shepherd’s departure from the board comes weeks after the long-awaited commercialisation of Visitect CD4, a product which allows field clinicians to measure the extent of the HIV virus in a carrier’s system and adjust medication accordingly. The solution could be worth £10m a year for the company. “It is a significant opportunity in front of us,” said Mr King. “A lot of questions in the past were whether we could bring this product to market. What we’ve proved is that yes we can, and we have, and really now it’s not a case of if but when we start seeing those significant revenues. There is a clear need for the product in the marketplace.” While the commercialisation of CD4 is a key milestone for the group, Mr King added: “There are other parts of our business we need to grow, not just in global health, but in food and allergy to drive the business and delivery shareholder value. That’s what I’ll be focused on as CEO.”
rivaldo
15/12/2017
15:24
Directors haven't bought in the open market for years, and something has changed, confidence in management, and we still have a seller even at 15.5p......
barrywhit
15/12/2017
15:18
Easy to lose some confidence but nothing much has changed. I would expect David Evans and other directors to buy shares if it stays this low.
longshanks
Chat Pages: 92  91  90  89  88  87  86  85  84  83  82  81  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20180116 09:36:32